This HTML5 document contains 65 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n11http://dx.doi.org/10.1161/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q57260329
rdf:type
wikibase:Item
schema:description
2014 ഏപ്രില്‍ 15 നു പ്രസിദ്ധീകരിച്ച ശാസ്ത്ര ലേഖനം наукова стаття, опублікована у квітні 2014 scholarly article by Morten Lamberts et al published 15 April 2014 in Circulation wetenschappelijk artikel article scientifique publié en 2014 im April 2014 veröffentlichter wissenschaftlicher Artikel
p:P577
wds:Q57260329-5160EE12-AD42-497F-8296-A3AE4F660134
wdt:P577
2014-04-15T00:00:00Z
p:P407
wds:Q57260329-292FF479-CBDF-4CCE-B80E-CF6E71DEEBAB
wdt:P407
wd:Q1860
p:P2093
wds:Q57260329-1A6C0BAC-C8AE-428C-BE0D-34AA4933186C wds:Q57260329-FD3FBA69-DD44-41EB-8233-31AF40BEF49E
wdt:P2093
Anders P. Mikkelsen Rikke Sørensen
rdfs:label
Antiplatelet Therapy for Stable Coronary Artery Disease in Atrial Fibrillation Patients Taking an Oral Anticoagulant Antiplatelet Therapy for Stable Coronary Artery Disease in Atrial Fibrillation Patients Taking an Oral Anticoagulant
skos:prefLabel
Antiplatelet Therapy for Stable Coronary Artery Disease in Atrial Fibrillation Patients Taking an Oral Anticoagulant Antiplatelet Therapy for Stable Coronary Artery Disease in Atrial Fibrillation Patients Taking an Oral Anticoagulant
schema:name
Antiplatelet Therapy for Stable Coronary Artery Disease in Atrial Fibrillation Patients Taking an Oral Anticoagulant Antiplatelet Therapy for Stable Coronary Artery Disease in Atrial Fibrillation Patients Taking an Oral Anticoagulant
p:P50
wds:Q57260329-FDF62D4E-DE62-4DF3-98C7-2BF655541774 wds:Q57260329-0B3D093E-C8B3-4DF7-807A-4B4D22612D1B wds:Q57260329-A9915CD4-45AE-44BE-A141-0E43BC0F4C56 wds:Q57260329-33E8F10A-FBAA-4086-BDE2-94BDC387D87F wds:Q57260329-EE0609B5-5BEC-4DC9-BA52-8363DAB29840 wds:Q57260329-F5A72277-0A56-4888-9D21-7280BC609DF9 wds:Q57260329-FBD6B078-6C37-46E7-AA3E-C7E020B18DDF wds:Q57260329-8BB69189-B718-46E7-A876-EF10C802C2D1
wdt:P50
wd:Q33310611 wd:Q33310590 wd:Q60393087 wd:Q78699620 wd:Q116772508 wd:Q114309734 wd:Q114294550 wd:Q33310632
p:P1476
wds:Q57260329-76BD8CC5-06FE-4D40-A81B-9BC5FFD3DC2D
wdt:P1476
Antiplatelet Therapy for Stable Coronary Artery Disease in Atrial Fibrillation Patients Taking an Oral Anticoagulant
p:P304
wds:Q57260329-F9CF66ED-B4CE-40E1-8617-0EF949A24CC7
wdt:P304
1577-1585
p:P31
wds:Q57260329-01D38076-2448-4FED-BF8C-F408BEE7B49E
wdt:P31
wd:Q13442814
p:P921
wds:Q57260329-A674D9FA-2DEF-4BAB-B2A4-9D8E5313212B wds:Q57260329-EB9112C7-B9D9-4761-801B-656E67A7025A wds:Q57260329-1135A477-7121-48B7-ABC0-AE2582DCBD2D wds:Q57260329-708CC69F-1CBC-49EF-ABEB-C254A448D06B wds:Q57260329-79F42FB0-EABA-4E0C-9CF8-97911E3DEE5C
wdt:P921
wd:Q844935 wd:Q815819 wd:Q63279445 wd:Q181600 wd:Q215118
p:P698
wds:Q57260329-70691031-F8B2-481B-9653-FEDE85C28FB1
wdtn:P698
n8:24470482
wdt:P698
24470482
p:P1433
wds:Q57260329-82ED5C4A-5CF7-4272-832D-F02278BDE1DC
wdt:P1433
wd:Q578091
p:P433
wds:Q57260329-DDD12877-64F2-454B-A33C-291542D49C69
p:P478
wds:Q57260329-8F506E60-920A-4E00-9687-29B783138FA2
wdt:P433
15
wdt:P478
129
p:P356
wds:Q57260329-6F971B25-6E67-4DA2-89EA-7EE71585FA91
wdtn:P356
n11:CIRCULATIONAHA.113.004834
wdt:P356
10.1161/CIRCULATIONAHA.113.004834